Confirmation of Essure Placement Using Transvaginal Ultrasound

Veersema, Sebastiaan; Vleugels, M.P.H.; Koks, C. A.M.; Thurkow, Andreas L.; Vaart, Huub van der; Brölmann, Hans A.M.

doi:10.1016/j.jmig.2010.10.010

Cited by 39 publications

(30 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The mean number of expanded coils that remained intracavitary extruding from the tubal ostium (4.42 ± 2.7 in the right side and 4.24 ± 2.4) shows that the microinserts were correctly placed in most cases. The rate of satisfactory placement and the rate of second attempts needed were consistent with previously published data [8] .…”

Section: Discussionsupporting

confidence: 90%

“…Following the Dutch protocol [8] , 108 (77.6%) HSG could have been avoided. In 18 patients (12.9%), the insertion was unsatisfactory and in 11 cases (7.9%), the insertion was satisfactory but 3D-US was inconclusive.…”

Section: Resultsmentioning

confidence: 99%

“…In that protocol, a transvaginal sonography was performed 3 months after the procedure as unique imaging test when device placement has been bilaterally satisfactory. This approach turned out to be as effective as the FDA protocol [8] .…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Utility of Three-Dimensional Ultrasonography to Assess the Position of Essure Tubal Occlusion Device and Its Complications

Alvarez-Lopez¹,

Santiago²,

Piñera³

et al. 2016

Gynecol Obstet Invest

View full text Add to dashboard Cite

Background: To determine the utility of three-dimensional (3D) sonography to control the position of hysteroscopic sterilizing device compared to hysterosalpingography (HSG). Methods: A prospective observational study was carried out on 139 patients who underwent hysteroscopic tubal occlusion method between February 2012 and May 2013. Patients underwent 3D ultrasound scan to control device positioning, and they also underwent HSG as an additional control method. Comparison between both methods was carried out. Results: In all, 17 (12.2%) devices were inserted due to a hydrosalpinx and 122 (87.8%) due to sterilization purposes. In 124 (89.2%) cases, sonography correlated completely to HSG findings. Sonography-positive predictive value was 89.5% to detect correct device positioning. Just 4 (2.8%) patients did not present complete tubal occlusion 3 months after device insertion; one of them presented device expulsion, 2 of them presented previous hydrosalpinx (tubal occlusion was confirmed after 6 months), and the last case rejected to undergo further controls but device seem to be effective. Conclusions: 3D sonography seems to be effective for the control of sterilization device positioning, but it also detects insertion complications and device migration. Further studies would be required to assess our findings and the role of sonography in case of hydrosalpinx.

show abstract

Section: Discussionsupporting

confidence: 90%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Utility of Three-Dimensional Ultrasonography to Assess the Position of Essure Tubal Occlusion Device and Its Complications

Alvarez-Lopez¹,

Santiago²,

Piñera³

et al. 2016

Gynecol Obstet Invest

View full text Add to dashboard Cite

show abstract

“…It has been demonstrated that micro-insert presence inside the interstitial portion of the Fallopian tube can be used as a proxy for tubal occlusion. [4][5][6][7][8] The ability to perform the test sooner than the currently recommended three months post procedure has the potential to increase patient compliance and reassure patients earlier of correct micro-insert placement.…”

Section: Discussionmentioning

confidence: 99%

“…Several studies have demonstrated that the presence of the device in the interstitial portion of the Fallopian tubes amounts to tubal occlusion with no increase in failure rates and ultrasound is associated with much lower reported discomfort and pain than the HSG. [4][5][6][7][8] The current recommendation for performing the confirmation test three months post-procedure is derived from a peri-hysterectomy study. Women undergoing elective hysterectomy agreed to have the Essure procedure prior to their surgery.…”

Section: Introductionmentioning

confidence: 99%